KIT Ligand antibody (AA 180-229)
Quick Overview for KIT Ligand antibody (AA 180-229) (ABIN604745)
Target
See all KIT Ligand (KITLG) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 180-229
-
Brand
- IHC-plus™
-
Specificity
- Human KITLG
-
Predicted Reactivity
- Percent identity by BLAST analysis: Rat, Horse, Chicken (100%) Guinea pig (92%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa180-229 of human KITLG (P21583, NP_000890). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Mouse, Rat, Sheep, Goat, Hamster, Elephant, Dog, Cat, Bovine, Rabbit, Horse, Pig, Opossum, Turkey, Zebra finch, Chicken (100%), Bat, Guinea pig, Platypus (92%), Marmoset (85%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: IHC, IHC-P (5 μg/mL), WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:1562500. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- KIT Ligand (KITLG)
-
Alternative Name
- KITLG / SCF
-
Background
-
Name/Gene ID: KITLG
Synonyms: KITLG, C-Kit ligand, KIT ligand, Kitl, KL-1, SHEP7, SF, Steel factor, Stem cell factor, SCF, FPH2, Mast cell growth factor, MGF -
Gene ID
- 4254
-
NCBI Accession
- NP_000890
-
UniProt
- P21583
-
Pathways
- RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
Target
-